The ESG Weekly: Should investors care about antibiotic resistance? And only a handful of companies are preventing a deforestation‐free supply chain for the week of November 18..
This week we discuss how companies are impacted by the Center for
Disease Control 's most recent report on antibiotic resistance, and
then Mario Lopez‐Alcala joins us to discuss the companies involved
in deforestation in South America, all through an ESG
14 Minuten
Podcast
Podcaster
Environmental, social, and governance (ESG) news and investment research brought to you weekly covering major market trends and new research insights.
Beschreibung
vor 6 Jahren
Two stories this week with ESG glasses: Antibiotic resistance ‐ the
ability of germs to defeat the drugs designed to kill them ‐ is one
of the greatest public health challenges of our time; but as the
crisis grows what will happen to the companies that produce
antibiotics (0:54)? And then Mario Lopez‐Alcala tells us which
companies are slowing the transition to a deforestation free supply
chain in South America (10:17), all through an ESG lens.
ability of germs to defeat the drugs designed to kill them ‐ is one
of the greatest public health challenges of our time; but as the
crisis grows what will happen to the companies that produce
antibiotics (0:54)? And then Mario Lopez‐Alcala tells us which
companies are slowing the transition to a deforestation free supply
chain in South America (10:17), all through an ESG lens.
Weitere Episoden
18 Minuten
vor 5 Jahren
17 Minuten
vor 5 Jahren
In Podcasts werben
Abonnenten
Pforzheim
Kommentare (0)